Karrels James 4

What Happened

• James Karrels, SVP and CFO of MacroGenics (MGNX), converted restricted stock units (RSUs) into 16,333 shares across Feb 7–8, 2026. To satisfy tax withholding obligations, 6,306 of those shares were surrendered at $1.81/share (total tax withholding reported $11,414), leaving a net issuance of 10,027 shares to him. These transactions are conversions of previously granted RSUs rather than open-market purchases or discretionary sales.

Key Details

• Transaction dates: Feb 7, 2026 (6,334 RSUs converted; 2,446 shares withheld) and Feb 8, 2026 (9,999 RSUs converted; 3,860 shares withheld).
• Withholding price reported: $1.81 per share; total withholding value $4,427 + $6,987 = $11,414.
• Net shares received: 16,333 converted − 6,306 withheld = 10,027 shares added to his holdings.
• Shares owned after transaction: not specified in the filing.
• Footnotes: F1 = RSUs convert one-for-one into common stock; F2 = some holdings owned jointly with his wife; F3/F4 = these RSUs came from grants (19,000 RSUs on 2/7/2025 and 30,000 RSUs on 2/8/2024) that vest in three installments — the converted amounts correspond to scheduled vesting installments.
• Filing: Form 4 filed Feb 10, 2026 for transactions dated Feb 7–8; filing appears timely.

Context

• This was a routine RSU vesting and tax-withholding event (common when RSUs vest). The filing shows a conversion and share withholding to cover taxes rather than a cash sale; such withholding is administrative and not necessarily a market sentiment signal. For clarity: M-coded entries indicate exercise/conversion of a derivative (here, RSUs); F-coded entries reflect shares surrendered to satisfy tax obligations.